{"mainPropery":{"diseaseId":4925,"diseaseName":"Spastic paraplegia 4","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4925/spastic-paraplegia-4","synonyms":["SPG4","Autosomal dominant spastic paraplegia 4","Familial spastic paraplegia autosomal dominant 2","FSP2"],"synonyms-with-source":[{"name":"SPG4"},{"name":"Autosomal dominant spastic paraplegia 4"},{"name":"Familial spastic paraplegia autosomal dominant 2"},{"name":"FSP2"}],"identifiers":[{"identifierType":"OMIM","identifierId":"182601"},{"identifierType":"ORPHANET","identifierId":"100985"},{"identifierType":"UMLS","identifierId":"C1866855"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":61,"resourceName":"Spastic Paraplegia Foundation","abbreviation":"SPF","address1":"1605 Goularte Place","address2":"","address3":"","address4":"","address5":"","city":"Fremont","state":"CA","zip":"94539-7241","country":"United States","phone":"1-877-773-4483 ","tty":"","tollFree":"","fax":"1-877-773-4483 ","email":"information@sp-foundation.org","url":"https://sp-foundation.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/182601' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=182601' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Spastic paraplegia 4. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-4' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Spastic paraplegia 4. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":346,"resourceId":1163,"resourceName":"RareConnect- Hereditary Spastic Paraplegia","descriptionText":"<a href='http://www.rareconnect.org/en/community/hereditary-spastic-paraplegia ' target='_blank'>RareConnect</a> is an online social network for patients and families to connect with one another and share their experience living with a rare disease. The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders). Click on the link above to view the community for Hereditary spastic paraplegia.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://rarediseases.org/rare-diseases/hereditary-spastic-paraplegia/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=100985' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1160/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:182601' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2136,"resourceId":61,"resourceName":"Spastic Paraplegia Foundation","descriptionText":"The <a href='http://sp-foundation.org/understanding-pls-hsp/hsp.html' target='_blank'>Spastic Paraplegia Foundation</a>, a nonprofit organization supporting spastic paraplegia, offers information on&nbsp;Spastic paraplegia 4","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":10700,"questionText":"What is spastic paraplegia 4?","answerText":"<strong>Spastic paraplegia 4 (SPG4)</strong>&nbsp;is the most common type of <a href=\"https://rarediseases.info.nih.gov/gard/6637/hereditary-spastic-paraplegia/resources/1\" target=\"_blank\">hereditary spastic paraplegia</a> (HSP) inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;manner. Disease onset ranges from infancy to older adulthood. SPG4 is characterized by slowly progressive muscle weakness and spasticity (stiff or rigid muscles) in the lower half of the body. In rare cases, individuals may have a more complex form with seizures, ataxia, and dementia. SPG4 is caused by&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>&nbsp;in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/SPAST\" target=\"_blank\">SPAST</a></em>&nbsp;gene.[11330][11599] Severity of symptoms usually worsens over time, however some individuals remain mildly affected throughout their lives.[11598] Medications, such as antispastic drugs and physical therapy may aid in stretching spastic muscles and preventing contractures (fixed tightening of muscles).[11330][11599]","dateModified":"2016-05-27T17:15:00"},"basicQuestions":[{"questionId":10701,"questionText":"What are the signs and symptoms of spastic paraplegia 4 (SPG4)?","answerText":"Signs and symptoms of SPG4 usually become apparent in young adulthood; although symptoms may start as early as one year of age and as late as 76 years. Characteristic symptoms include stiff and rigid muscles (spasticity) and weakness in both of the legs and the lower portion of the body. Additional symptoms are different for every affected individual. Other symptoms may include:[11599][11330]<br />\r\n<ul>\r\n    <li>Decreased ability to sense vibrations in the ankles</li>\r\n    <li>Exaggerated reflexes (hyperreflexia)</li>\r\n    <li>Ankle spasms</li>\r\n    <li>High arches in the feet (pes cavus)</li>\r\n    <li>Reduced bladder control</li>\r\n    <li>Ataxia (lack of muscle control)</li>\r\n    <li>Seizures</li>\r\n</ul>\r\nSome individuals may also experience a mild decline in cognitive function. This decline does not typically affect daily functioning.[11598]","dateModified":"2016-05-27T17:32:00","resourceClassificationName":"Symptoms","references":[{"referenceId":11330,"authors":"Nance MA","articleTitle":"Hereditary Spastic Paraplegia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/hereditary-spastic-paraplegia/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11598,"authors":"Dürr A, Tallaksen C, Depienne C","articleTitle":"Spastic Paraplegia 4","bookWebsiteJournalTitle":"GeneReveiws","date":"Aug 16 2012","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1160","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11599,"authors":"","articleTitle":"Spastic paraplegia 4","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January 2008","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-4","dateAccessed":"2016-05-27T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10703,"questionText":"How is spastic paraplegia 4 (SPG4) inherited?","answerText":"SPG4 is inherited in an&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>&nbsp;manner.[11599] This means that having a change (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in only one copy of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell is enough to cause features of the condition.<br />\r\n<br />\r\nIn some cases, an affected person inherits the mutated gene from an affected parent. In other cases, the mutation occurs for the first time in a person with no family history of the condition. This is called a&nbsp;<em><a href=\"http://ghr.nlm.nih.gov/glossary=denovomutation\" target=\"_blank\">de novo</a></em>&nbsp;mutation.<br />\r\n<br />\r\nWhen a person with a mutation that causes an autosomal dominant condition has children, each child has a 50% (1 in 2) chance to inherit that mutation.","dateModified":"2016-05-27T17:45:00","resourceClassificationName":"Inheritance","references":[{"referenceId":11599,"authors":"","articleTitle":"Spastic paraplegia 4","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January 2008","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-4","dateAccessed":"2016-05-27T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10702,"questionText":"How might spastic paraplegia 4 (SPG4) be treated?","answerText":"Care for SPG4 is usually managed by a team including a&nbsp;<a href=\"http://kidshealth.org/en/parents/primary-care-physician.html\" target=\"_blank\">primary care physician</a>,&nbsp;<a href=\"https://patients.aan.com/go/workingwithyourdoctor\" target=\"_blank\">neurologist</a>, genetics professional (<a href=\"http://www.ashg.org/education/careers.shtml\" target=\"_blank\">geneticist</a>&nbsp;and/or&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/geneticcounseling.html\" target=\"_blank\">genetic counselor</a>),<a href=\"http://kidshealth.org/en/kids/physical-therapy.html\" target=\"_blank\">&nbsp;physical therapist</a>,&nbsp;<a href=\"https://www.socialworkers.org/pressroom/features/general/profession.asp\" target=\"_blank\">social worker</a>, and&nbsp;<a href=\"http://www.apa.org/helpcenter/about-psychologists.aspx\" target=\"_blank\">psychologist</a>. Treatment is focused on alleviating symptoms and may include:[11598]<br />\r\n<ul>\r\n    <li>Medications for leg spasticity (antispastic drugs)</li>\r\n    <li>Medications to assist in bladder control (anticholinergic antispasmodic drugs)&nbsp;</li>\r\n    <li>Regular physician therapy</li>\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/botox.html\" target=\"_blank\">Botulinum toxin</a>&nbsp;and&nbsp;<a href=\"http://www.mayoclinic.org/drugs-supplements/baclofen-intrathecal-route/description/drg-20062155\" target=\"_blank\">intrathecal baclofen</a>&nbsp;for severe spasticity&nbsp;</li>\r\n</ul>","dateModified":"2016-05-27T17:40:00","resourceClassificationName":"Treatment","references":[{"referenceId":11598,"authors":"Dürr A, Tallaksen C, Depienne C","articleTitle":"Spastic Paraplegia 4","bookWebsiteJournalTitle":"GeneReveiws","date":"Aug 16 2012","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1160","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10704,"questionText":"What is the long term outlook for spastic paraplegia 4 (SPG4)?","answerText":"The severity of symptoms in SPG4 generally worsen over time; however, some individuals may have mild symptoms throughout their lives. Approximately 17% of individuals eventually use a wheelchair, while approximately 20% use assistance (such as a walker) to walk.[11598]","dateModified":"2016-05-27T17:50:00","resourceClassificationName":"Prognosis","references":[{"referenceId":11598,"authors":"Dürr A, Tallaksen C, Depienne C","articleTitle":"Spastic Paraplegia 4","bookWebsiteJournalTitle":"GeneReveiws","date":"Aug 16 2012","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1160","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12747,"relatedDiseaseName":"Hereditary spastic paraplegia - autosomal dominant inheritance","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4289,"phenoTypeName":"Ankle clonus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10650,"phenoTypeName":"Brisk reflexes","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3587,"phenoTypeName":"Functional motor deficit","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1623,"phenoTypeName":"Impaired vibration sensation at ankles","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3438,"phenoTypeName":"Leg muscle stiffness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13670,"phenoTypeName":"Lower limb muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13449,"phenoTypeName":"Lower limb spasticity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6543,"phenoTypeName":"Urinary urgency","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5271,"phenoTypeName":"Distal amyotrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13673,"phenoTypeName":"Hyperreflexia in upper limbs","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7928,"phenoTypeName":"Urinary bladder sphincter dysfunction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6013,"phenoTypeName":"Aggressive behavior","percentRanges":"-"},{"phenoTypeId":6010,"phenoTypeName":"Agitation","percentRanges":"-"},{"phenoTypeId":14134,"phenoTypeName":"Apathy","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":11408,"phenoTypeName":"Degeneration of the lateral corticospinal tracts","percentRanges":"-"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","percentRanges":"-"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","percentRanges":"-"},{"phenoTypeId":14128,"phenoTypeName":"Disinhibition","percentRanges":"-"},{"phenoTypeId":5308,"phenoTypeName":"Genetic anticipation","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":13841,"phenoTypeName":"Impaired vibration sensation in the lower limbs","percentRanges":"-"},{"phenoTypeId":6244,"phenoTypeName":"Insidious onset","percentRanges":"-"},{"phenoTypeId":5595,"phenoTypeName":"Low back pain","percentRanges":"-"},{"phenoTypeId":11437,"phenoTypeName":"Memory impairment","percentRanges":"-"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","percentRanges":"-"},{"phenoTypeId":14239,"phenoTypeName":"Paraplegia","percentRanges":"-"},{"phenoTypeId":5255,"phenoTypeName":"Progressive","percentRanges":"-"},{"phenoTypeId":13452,"phenoTypeName":"Spastic gait","percentRanges":"-"},{"phenoTypeId":8712,"phenoTypeName":"Spastic paraplegia","percentRanges":"-"},{"phenoTypeId":6356,"phenoTypeName":"Urinary incontinence","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Spastic_paraplegia_4"}